Announced Fri, 3 Jul · 17:21 IST
Piramal Pharma submits BRSR for FY2025-26 with limited assurance
Compliance View source PDF
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹175.61
prior close
₹176.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.8-1.7-1.1-1.1-0.4-4.3-2.0+0.6-1.0-2.3+9.3———
Up moveDown movePending
AI summary
Piramal Pharma filed its BRSR for FY2025-26 with limited assurance from DNV. Standalone turnover Rs 4,782 crore and net worth Rs 8,859 crore. Exports are 72.78 percent across 100 plus countries. Workforce totals 6,774 employees and 3,666 workers. Targets include 42 percent Scope 1 and 2 emission cut and 25 percent Scope 3 cut by FY2030. A Gujarat Pollution Control Board notice required Rs 15 lakh bank guarantee plus Rs 1 crore environmental compensation.
Likely market impact
Routine compliance filing with limited new disclosures. The GPCB environmental notice and capex on emission cuts are the items to monitor.